跳至主要内容
临床试验/CTRI/2022/05/042366
CTRI/2022/05/042366已完成2 期

A Randomized Controlled Clinical Trial to Evaluate the Immunomodulatory Profile of a Polyherbal Compound OC22 on Apparently Healthy Volunteers

Ms Saatvik Enterprises0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1-Apparently Healthy individuals aged 20-40 years of either sex.
  • 2-Individuals giving consent for participation.

排除标准

  • 1-Individuals with chronic co-morbid conditions which might have affected the immune status of the individual.
  • 2-Pregnant or lactating mother
  • 3-Person on any interventional drug like vitamin/mineral/hormonal supplements/protein supplements etc. or any other nutritional supplements

研究者

发起方
Ms Saatvik Enterprises

相似试验

A clinical trial to study the effects of a... | 临床试验